CIK 0001798749
- Emerging growth company
Jade Biosciences, Inc.
Sign in to watch- Ticker
- JBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831377888
- Phone
- +1 781-312-3013
- Business address
- 221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aerovate Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Katabi Maha Director | Grant or award · Stock Option (Right to Buy) | +3,519 | $13.49 | $47K | 3,519 |
| 2024-01-02 | GRAYZEL DAVID S. Director | Grant or award · Stock Option (Right to Buy) | +3,186 | $13.49 | $43K | 3,186 |
| 2023-12-27 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +125 | $2.14 | $268 | 3,376 |
| 2023-12-27 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale 10b5-1 | −125 | $24.50 | $3K | 3,251 |
| 2023-12-27 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25 | 16,269 | ||
| 2023-12-27 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100 | 109,540 | ||
| 2023-12-20 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale 10b5-1 | −4,000 | $19.50 | $78K | 3,251 |
| 2023-12-20 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,924 | 9,023 | ||
| 2023-12-20 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,076 | 10,027 | ||
| 2023-12-14 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +9,897 | $1.74 | $17K | 13,148 |
| 2023-12-14 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale 10b5-1 | −9,897 | $19.50 | $193K | 3,251 |
| 2023-12-14 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,700 | 12,744 | ||
| 2023-12-14 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,197 | 10,306 | ||
| 2023-12-13 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +4,000 | $1.74 | $7K | 7,251 |
| 2023-12-13 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +2,103 | $1.74 | $4K | 5,354 |
| 2023-12-13 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,103 | $19.50 | $41K | 3,251 |
| 2023-12-13 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −653 | 15,444 | ||
| 2023-12-13 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,450 | 17,503 | ||
| 2023-12-06 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +2,411 | $1.74 | $4K | 3,702 |
| 2023-12-06 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +7,872 | $2.14 | $17K | 11,574 |
Page 10 of 16 · 315 trades